Merck & Co Inc
NYSE: MRK
$100.09
+$0.44 (+0.4%)
Closing Price on January 15, 2025
MRK Articles
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest...
Published:
Short sellers upped their investments in stocks of the most prominent financial firms. Short interest in Bank of America (BAC), AIG (AIG), Wells Fargo (WFC), and Freddie Mac (FRE) all rose for the...
Published:
Last Updated:
There is still some conversation about the federal government restricting short-selling activity in certain stocks. The counterargument to these restrictions is that short selling plays an important...
Published:
Last Updated:
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program under the Obama administration and with a Democratic Congress. What is certain...
Published:
The short interest in most large banks fell very sharply for the period ending May 29, an indication that traders believe that TARP repayments and ongoing strong earnings mean the fate of American...
Published:
Last Updated:
Reuters: GM and Chrysler said closing dealers was essential to their restructuring. Reuters: The Justice Department is probing big tech employee recruiting. Reuters: Medical bills...
Published:
Last Updated:
Investors flock to defensive stocks in times of trouble and and when they worry, assuming they look to stay in the market when they are worried. But if the trend here continues, this may be one of...
Published:
Twelve of the Fortune 500 CEOs are women. Just twelve. Over the next year, that number is likely to go up considerably because of a confluence of economic and financial factors that have not existed...
Published:
Last Updated:
There have been some pretty poor reports on earnings from DJIA components such as Caterpillar Inc. (NYSE: CAT), The Coca-Cola Company (NYSE: KO), EI DuPont de Nemours & Co. (NYSE: DD),...
Published:
Last Updated:
Merck released earnings, and cut its forecasts. No wonder. Its Q1 numbers were atrocious. Revenue for the first quarter of 2009 was $5.4 billion, a decrease of 8%compared to the first quarter of...
Published:
According to The Wall Street Journal, large US companies held their R&D spending steady in the fourth quarter of last year even though in most cases their revenue fell. According to the paper,...
Published:
Last Updated:
At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March 9th. The bank stocks continue an extraordinary run over that period. Citigroup (C) is up 120%...
Published:
Last Updated:
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that can be put to work...
Published:
Last Updated:
According to Reuters, Obama faces backlash due to AIG (AIG) compensation issues which could set bank his efforts to salvage the financial system. Reuters reports that Lehman will put two of its...
Published:
Last Updated:
Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1 billion. In reality, Merck is making an acquisition. Its shares will be the currency to compete the...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.